ES428889A1 - Procedimiento de preparacion de derivados de acido prosta- noico. - Google Patents

Procedimiento de preparacion de derivados de acido prosta- noico.

Info

Publication number
ES428889A1
ES428889A1 ES428889A ES428889A ES428889A1 ES 428889 A1 ES428889 A1 ES 428889A1 ES 428889 A ES428889 A ES 428889A ES 428889 A ES428889 A ES 428889A ES 428889 A1 ES428889 A1 ES 428889A1
Authority
ES
Spain
Prior art keywords
alpha
acid derivatives
prostanoic acid
stadien
tetranor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES428889A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of ES428889A1 publication Critical patent/ES428889A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES428889A 1973-08-02 1974-08-02 Procedimiento de preparacion de derivados de acido prosta- noico. Expired ES428889A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3669173A GB1451798A (en) 1973-08-02 1973-08-02 Prostanoic acid derivatives

Publications (1)

Publication Number Publication Date
ES428889A1 true ES428889A1 (es) 1976-09-01

Family

ID=10390378

Family Applications (1)

Application Number Title Priority Date Filing Date
ES428889A Expired ES428889A1 (es) 1973-08-02 1974-08-02 Procedimiento de preparacion de derivados de acido prosta- noico.

Country Status (24)

Country Link
US (1) US3954881A (es)
JP (1) JPS5069045A (es)
AR (1) AR204013A1 (es)
AT (1) AT341119B (es)
BE (1) BE818396A (es)
CH (1) CH605511A5 (es)
CS (1) CS174785B2 (es)
DD (1) DD114401A5 (es)
DE (1) DE2437388A1 (es)
DK (1) DK410174A (es)
EG (1) EG11489A (es)
ES (1) ES428889A1 (es)
FI (1) FI232274A (es)
FR (1) FR2239995B1 (es)
GB (1) GB1451798A (es)
IE (1) IE40157B1 (es)
IL (1) IL45299A (es)
IN (1) IN138940B (es)
LU (1) LU70639A1 (es)
NL (1) NL7410343A (es)
NO (1) NO742713L (es)
SE (1) SE7409930L (es)
ZA (1) ZA744509B (es)
ZM (1) ZM12074A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1468830A (en) * 1974-01-26 1977-03-30 May & Baker Ltd Cyclopentane derivatives
US4183870A (en) * 1974-01-26 1980-01-15 May & Baker Limited Cyclopentane derivatives
GB1506816A (en) * 1975-03-31 1978-04-12 Upjohn Co Prostaglandins
NL7605381A (nl) * 1975-05-26 1976-11-30 Schering Ag Werkwijze voor het bereiden van prostaanderi- vaten en werkwijze voor het bereiden van een geneesmiddel met prostaglandinewerking.
US4388457A (en) * 1982-02-11 1983-06-14 University Patents, Inc. Phyllanthostatin compounds
IL93936A (en) * 1989-03-28 1994-06-24 Abbott Lab History of 9-dioxo-21,9-epoxy - erythromycin, method of preparation History of 11-oxo and 11-hydroxy, and pharmaceutical preparations containing them
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US6184250B1 (en) 1993-08-03 2001-02-06 Alcon Laboratories, Inc. Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension
US5721273A (en) 1993-12-15 1998-02-24 Alcon Laboratories, Inc. Use of certain 9-halo-13,14-dihydroprostaglandins to treat glaucoma and ocular hypertension
EP1008588B1 (en) * 1997-02-10 2003-04-16 Ono Pharmaceutical Co., Ltd. 11,15-o-dialkylprostaglandin e derivatives, process for producing the same, and drugs containing the same as the active ingredient
US7842677B2 (en) * 2001-08-29 2010-11-30 Seneb Biosciences, Inc. Synthetic ganglioside derivatives and compositions thereof
WO2004099231A2 (en) 2003-04-09 2004-11-18 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
WO2005012484A2 (en) 2003-07-25 2005-02-10 Neose Technologies, Inc. Antibody-toxin conjugates
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US20080300173A1 (en) 2004-07-13 2008-12-04 Defrees Shawn Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
EP1814573B1 (en) 2004-10-29 2016-03-09 ratiopharm GmbH Remodeling and glycopegylation of fibroblast growth factor (fgf)
EP1814569A2 (en) * 2004-11-09 2007-08-08 Neose Technologies, Inc. Glycolipids
CA2593682C (en) 2005-01-10 2016-03-22 Neose Technologies, Inc. Glycopegylated granulocyte colony stimulating factor
US9187546B2 (en) 2005-04-08 2015-11-17 Novo Nordisk A/S Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
WO2007056191A2 (en) 2005-11-03 2007-05-18 Neose Technologies, Inc. Nucleotide sugar purification using membranes
JP2009544327A (ja) 2006-07-21 2009-12-17 ノヴォ ノルディスク アー/エス O−結合型グリコシル化配列によるペプチドのグリコシル化
EP2054521A4 (en) 2006-10-03 2012-12-19 Novo Nordisk As METHODS OF PURIFYING CONJUGATES OF POLYPEPTIDES
KR20150064246A (ko) 2007-04-03 2015-06-10 바이오제너릭스 게엠베하 글리코페길화 g―csf를 이용하는 치료 방법
ES2551123T3 (es) 2007-06-12 2015-11-16 Ratiopharm Gmbh Proceso mejorado para la producción de azúcares de nucleótido
CN101965200B (zh) 2008-02-27 2013-06-19 诺沃-诺迪斯克有限公司 缀合的因子ⅷ分子
WO2010111530A1 (en) 2009-03-25 2010-09-30 Seneb Biosciences, Inc. Glycolipids as treatment for disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1334952A (en) * 1971-01-06 1973-10-24 Ici Ltd Cyclopentane derivat-ves and a process for their manufacture

Also Published As

Publication number Publication date
IL45299A (en) 1978-06-15
FR2239995A1 (es) 1975-03-07
CH605511A5 (es) 1978-09-29
AT341119B (de) 1978-01-25
IE40157L (en) 1975-02-02
AR204013A1 (es) 1975-11-12
NO742713L (es) 1975-03-03
SE7409930L (es) 1975-02-03
EG11489A (en) 1978-06-30
ATA635674A (de) 1977-05-15
JPS5069045A (es) 1975-06-09
FI232274A (es) 1975-02-03
AU7163574A (en) 1976-01-29
IL45299A0 (en) 1974-10-22
IE40157B1 (en) 1979-03-28
FR2239995B1 (es) 1978-07-21
ZM12074A1 (en) 1976-11-22
DK410174A (es) 1975-04-01
US3954881A (en) 1976-05-04
BE818396A (fr) 1975-02-03
DE2437388A1 (de) 1975-02-13
CS174785B2 (es) 1977-04-29
NL7410343A (nl) 1975-02-04
ZA744509B (en) 1975-07-30
LU70639A1 (es) 1974-12-10
DD114401A5 (es) 1975-08-05
IN138940B (es) 1976-04-17
GB1451798A (en) 1976-10-06

Similar Documents

Publication Publication Date Title
ES428889A1 (es) Procedimiento de preparacion de derivados de acido prosta- noico.
YU39026B (en) Process for preparing substituted 2,6-dimethylanilides of furan-2-carboxylic acid
YU73575A (en) Process for preparing 16-oxygenated prostanoic acid derivatives
ZA753722B (en) Process for the preparation of analogues of daunomycin
SE7612262L (sv) Ketofosfonat-mellanprodukter och forfarande for framstellning derav
IE37602L (en) Cyclocpentane derivatives
ES419143A1 (es) Procedimiento para la obtencion de derivados del acido prostanoico.
ES441358A1 (es) Procedimiento para la preparacion directa de carbonatos al- quilenicos.
IL47237A (en) 15-hydroxy-13-thia prostanoic acid analogues,process for their preparation and pharmaceutical compositions containing them
AU497401B2 (en) Prostaglandin compositions
ES441404A1 (es) Un procedimiento de preparacion de acido 5-fluor-2-metil-1- (p-metilsulfinil-benciliden) indenil-3-acetico.
CS190489B2 (en) Method of producing novel derivatives of prostanoic acid
CH609970A5 (en) Process for the preparation of novel prostanoic acid analogues which are not naturally occurring
ES443574A1 (es) Procedimiento para la obtencion de derivados de ciclopenta- no.
ES436832A1 (es) Procedimiento para preparar derivados del acido prostanoi- co.
ES440046A1 (es) Un procedimiento para la preparacion del antibiotico xk-62- 2.
ZA747430B (en) Novel, not naturally occurring analogues of prostanoic acids and process for their manufacture
ES461837A1 (es) Procedimiento para la preparacion de derivados de prostano.
HU173114B (hu) Novyj sposob poluchenija f vniz 2 al'fa prostaglandina i ego analogov
JPS5557560A (en) Prostane derivative*its manufacture and medicine and veterinary drug composition containing it
ES8506351A1 (es) Un procedimiento para producir un compuesto de antraciclina
ES394667A1 (es) Procedimiento de preparacion de derivados del acido prosta-noico.
ES8203087A1 (es) Procedimiento para la obtencion de imidazolil-indeno-tiofe- nos
ES438725A1 (es) Un procedimiento de preparacion de derivados sustituidos del acido prostanoico.
FR2326184A1 (fr) Analogues de prostaglandines et leur preparation